Data lock refers to the point in a clinical trial when all data collection and cleaning activities are completed, and no further changes can be made to the dataset. This process ensures that the final dataset used for analysis is complete, accurate, and unchangeable, maintaining the integrity of the study results.
The data lock typically occurs after all queries have been resolved, all protocol deviations have been documented, and the database has undergone thorough quality control checks. Once the data is locked, it becomes the basis for all subsequent statistical analyses and reporting, including the creation of tables, listings, and figures for the clinical study report.
Data lock is crucial in clinical research as it establishes a definitive endpoint for data collection and modification, ensuring the reliability and reproducibility of study results. This process prevents any unauthorized or accidental changes to the dataset after analysis has begun, maintaining the scientific integrity of the trial and supporting regulatory compliance.
The importance of data lock extends to the credibility of clinical research findings and their potential impact on medical practice and drug development. By creating a clear demarcation between data collection and analysis phases, data lock allows for unbiased interpretation of results and facilitates transparent reporting to regulatory authorities, healthcare professionals, and the public.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant